[HTML] sciencedirect.com

[HTML][HTML] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in radiation …, 2016 - Elsevier
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …
被引用次数：5 相关文章
[HTML] advancesradonc.com

[HTML][HTML] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in …, 2016 - advancesradonc.com
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …
[HTML] advancesradonc.com

[HTML][HTML] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in …, 2016 - advancesradonc.com
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …
[PDF] cyberleninka.org

[PDF][PDF] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, FY de Moraes, DE Spratt… - cancer, 2016 - cyberleninka.org
Objective: The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …
[HTML] advancesradonc.org

[HTML][HTML] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in …, 2016 - advancesradonc.org
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …
[HTML] nih.gov

[HTML][HTML] Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in …, 2016 - ncbi.nlm.nih.gov
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk …

R Gadia, ETT Leite, AL Bierrenbach… - Advances in …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk …

R Gadia, TL ET, AL Bierrenbach… - Advances in …, 2016 - europepmc.org
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk …

R Gadia, TL ET, AL Bierrenbach… - Advances in …, 2016 - europepmc.org
Objective The addition of androgen deprivation therapy (ADT) to conventional radiation
therapy improves overall survival (OS) in intermediate-and high-risk prostate cancer. The …